A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Inogen Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 16,900 shares of INGN stock, worth $137,397. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,900
Previous 1,400 1107.14%
Holding current value
$137,397
Previous $7,000 1842.86%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$5.26 - $10.15 $169,303 - $326,698
32,187 Added 68.95%
78,871 $636,000
Q4 2023

Feb 14, 2024

BUY
$4.21 - $6.32 $62,324 - $93,561
14,804 Added 46.44%
46,684 $256,000
Q3 2023

Nov 14, 2023

SELL
$5.14 - $11.28 $2.15 Million - $4.72 Million
-418,525 Reduced 92.92%
31,880 $166,000
Q2 2023

Aug 14, 2023

BUY
$10.01 - $13.86 $3.64 Million - $5.04 Million
363,973 Added 421.11%
450,405 $5.2 Million
Q1 2023

May 15, 2023

BUY
$11.88 - $26.0 $1.03 Million - $2.25 Million
86,432 New
86,432 $1.08 Million
Q3 2022

Nov 14, 2022

BUY
$22.74 - $31.8 $191,743 - $268,137
8,432 Added 54.79%
23,821 $578,000
Q2 2022

Aug 15, 2022

BUY
$22.88 - $35.28 $352,100 - $542,923
15,389 New
15,389 $372,000
Q1 2022

May 16, 2022

SELL
$28.1 - $35.25 $2.99 Million - $3.75 Million
-106,330 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$29.66 - $44.0 $1.3 Million - $1.94 Million
43,995 Added 70.58%
106,330 $3.62 Million
Q3 2021

Nov 15, 2021

SELL
$43.09 - $82.26 $6.17 Million - $11.8 Million
-143,164 Reduced 69.67%
62,335 $2.69 Million
Q2 2021

Aug 16, 2021

BUY
$52.03 - $68.77 $4.84 Million - $6.4 Million
93,020 Added 82.7%
205,499 $13.4 Million
Q1 2021

May 17, 2021

BUY
$43.96 - $55.99 $3.67 Million - $4.68 Million
83,528 Added 288.52%
112,479 $5.91 Million
Q4 2020

Feb 16, 2021

BUY
$27.19 - $44.68 $582,953 - $957,939
21,440 Added 285.45%
28,951 $1.29 Million
Q3 2020

Nov 16, 2020

SELL
$27.01 - $37.31 $2.13 Million - $2.94 Million
-78,824 Reduced 91.3%
7,511 $218,000
Q2 2020

Aug 14, 2020

BUY
$32.85 - $53.77 $1.45 Million - $2.38 Million
44,243 Added 105.11%
86,335 $3.07 Million
Q1 2020

May 15, 2020

BUY
$32.63 - $67.59 $1.28 Million - $2.64 Million
39,102 Added 1307.76%
42,092 $2.17 Million
Q4 2019

Feb 14, 2020

SELL
$45.95 - $76.15 $7 Million - $11.6 Million
-152,361 Reduced 98.08%
2,990 $204,000
Q3 2019

Nov 14, 2019

BUY
$41.82 - $66.71 $4.56 Million - $7.27 Million
108,985 Added 235.05%
155,351 $7.44 Million
Q2 2019

Aug 14, 2019

SELL
$63.19 - $95.15 $14.6 Million - $22 Million
-230,710 Reduced 83.27%
46,366 $3.1 Million
Q1 2019

May 15, 2019

SELL
$90.12 - $152.23 $12.2 Million - $20.6 Million
-135,558 Reduced 32.85%
277,076 $0
Q4 2018

Feb 14, 2019

BUY
$112.83 - $239.74 $43.2 Million - $91.8 Million
382,919 Added 1288.64%
412,634 $51.2 Million
Q3 2018

Nov 13, 2018

BUY
$189.1 - $282.92 $4.77 Million - $7.14 Million
25,249 Added 565.36%
29,715 $0
Q2 2018

Aug 10, 2018

SELL
$123.8 - $192.48 $370,409 - $575,900
-2,992 Reduced 40.12%
4,466 $0
Q1 2018

May 11, 2018

BUY
$114.22 - $133.22 $455,966 - $531,814
3,992 Added 115.18%
7,458 $916,000
Q4 2017

Feb 09, 2018

SELL
$93.4 - $128.74 $904,765 - $1.25 Million
-9,687 Reduced 73.65%
3,466 $413,000
Q3 2017

Nov 09, 2017

BUY
$91.08 - $104.49 $1.2 Million - $1.37 Million
13,153
13,153 $1.25 Million

Others Institutions Holding INGN

About Inogen Inc


  • Ticker INGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,866,500
  • Market Cap $186M
  • Description
  • Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...
More about INGN
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.